TriangleLITT + Lomustine (NCT07145112)
LITT + Lomustine trial for Recurrent Glioblastoma (NCT07145112). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with glioblastoma that has come back or progressed after earlier treatment.
The idea: combine laser interstitial thermal therapy, an MRI guided laser procedure that heats the tumor, followed by lomustine, a chemotherapy pill.
This phase 1 study plans 25 patients. It looks at the safety of the combination and whether patients can complete it in the planned timeframe. At the University of California, Davis, Orwa Aboud leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.